JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 45:2022-2025, doi:10.1016/j.jacc.2005.02.077
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hauser, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauser, R. G.

CLINICAL RESEARCH: HEART RHYTHM DISORDER: VIEWPOINT

The Growing Mismatch Between Patient Longevity and the Service Life of Implantable Cardioverter-Defibrillators

Robert G. Hauser, MD, FACC*

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.

Manuscript received January 17, 2005; revised manuscript received February 22, 2005, accepted February 28, 2005.

* Reprint requests and correspondence: Dr. Robert G. Hauser, Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 300, Minneapolis, Minnesota 55407. (Email: rhauser747{at}aol.com).

Implantable cardioverter-defibrillators (ICDs) are lifesaving devices. Over 100,000 patients received ICDs in 2004 at a cost of $2 billion for the pulse generators alone. Because of expanded indications and coverage by Medicare, the number of ICD implantations and replacements is expected to increase dramatically during the next decade. The average ICD patient at our institution now lives nearly 10 years after the procedure. However, the service life of pulse generators has decreased from 4.7 ± 1 year for single-chamber units to 4.0 ± 1 year for dual-chamber devices. This mismatch between patient longevity and the service life of ICDs poses a significant clinical and economic burden that must be addressed. One near-term solution is for manufacturers to provide devices with larger batteries so that most patients can have an ICD pulse generator that lasts a lifetime. For the long-term, more robust or renewable energy sources are needed.

Abbreviations and Acronyms
  CRT = cardiac resynchronization therapy
  ICD = implantable cardioverter-defibrillator
  QALY = quality-adjusted life year




This article has been cited by other articles:


Home page
CirculationHome page
D. B. Mark, C. L. Nelson, K. J. Anstrom, S. M. Al-Khatib, A. A. Tsiatis, P. A. Cowper, N. E. Clapp-Channing, L. Davidson-Ray, J. E. Poole, G. Johnson, et al.
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Circulation, July 11, 2006; 114(2): 135 - 142.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. D. Sanders, M. A. Hlatky, and D. K. Owens
Cost-Effectiveness of Implantable Cardioverter-Defibrillators
N. Engl. J. Med., October 6, 2005; 353(14): 1471 - 1480.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. G. Hauser and B. J. Maron
Lessons From the Failure and Recall of an Implantable Cardioverter-Defibrillator
Circulation, September 27, 2005; 112(13): 2040 - 2042.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.